216 related articles for article (PubMed ID: 23723740)
1. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
Tan CE; Kyriss T; Glantz SA
PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
[TBL] [Abstract][Full Text] [Related]
2. Irreconcilable conflict: the tobacco industry and the public health challenge of tobacco use.
Novotny TE
PLoS Med; 2013; 10(5):e1001457. PubMed ID: 23723744
[TBL] [Abstract][Full Text] [Related]
3. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
Tong EK; England L; Glantz SA
Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
[TBL] [Abstract][Full Text] [Related]
4. Tobacco industry lawyers as "disease vectors".
Guardino SD; Daynard RA
Tob Control; 2007 Aug; 16(4):224-8. PubMed ID: 17652236
[TBL] [Abstract][Full Text] [Related]
5. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
Jenson D; Lester J; Berman ML
Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
[TBL] [Abstract][Full Text] [Related]
6. Destroyed documents: uncovering the science that Imperial Tobacco Canada sought to conceal.
Hammond D; Chaiton M; Lee A; Collishaw N
CMAJ; 2009 Nov; 181(10):691-8. PubMed ID: 19828670
[TBL] [Abstract][Full Text] [Related]
7. No sisyphean task: how the FDA can regulate electronic cigarettes.
Paradise J
Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
[TBL] [Abstract][Full Text] [Related]
8. Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation.
Velicer C; Lempert LK; Glantz S
Tob Control; 2015 Sep; 24(5):469-80. PubMed ID: 24920577
[TBL] [Abstract][Full Text] [Related]
9. Policy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk.
Givel M
Curr Drug Abuse Rev; 2008 Jun; 1(2):135-41. PubMed ID: 19630712
[TBL] [Abstract][Full Text] [Related]
10. The need for FDA regulation of tobacco products.
Kennedy EM
Yale J Health Policy Law Ethics; 2002; 3(1):101-8. PubMed ID: 12825428
[No Abstract] [Full Text] [Related]
11. Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future.
Husten CG; Deyton LR
Lancet; 2013 May; 381(9877):1570-80. PubMed ID: 23642698
[TBL] [Abstract][Full Text] [Related]
12. Tobacco-control policies in tobacco-growing states: where tobacco was king.
Fallin A; Glantz SA
Milbank Q; 2015 Jun; 93(2):319-58. PubMed ID: 26044632
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
Douglas CE; Davis RM; Beasley JK
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
[TBL] [Abstract][Full Text] [Related]
14. Heat-not-Burn Tobacco Products: Tobacco Industry Claims No Substitute for Science.
Jenssen BP; Walley SC; McGrath-Morrow SA
Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29233936
[No Abstract] [Full Text] [Related]
15. Tobacco industry and public health responses to state and local efforts to end tobacco sales from 1969-2020.
McDaniel PA; Malone RE
PLoS One; 2020; 15(5):e0233417. PubMed ID: 32442202
[TBL] [Abstract][Full Text] [Related]
16. Substantial Equivalence Standards in Tobacco Governance: Statutory Clarity and Regulatory Precedent for the FSPTCA.
Carpenter D; Connolly GN; Lempert LK
J Health Polit Policy Law; 2017 Aug; 42(4):607-644. PubMed ID: 27864349
[TBL] [Abstract][Full Text] [Related]
17. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
[TBL] [Abstract][Full Text] [Related]
18. Tobacco products sold by Internet vendors following restrictions on flavors and light descriptors.
Jo CL; Williams RS; Ribisl KM
Nicotine Tob Res; 2015 Mar; 17(3):344-9. PubMed ID: 25173777
[TBL] [Abstract][Full Text] [Related]
19. Tobacco company strategies to identify and promote the benefits of nicotine.
Ling PM; Glantz SA
Tob Control; 2019 May; 28(3):289-296. PubMed ID: 30093414
[TBL] [Abstract][Full Text] [Related]
20. Understanding Philip Morris's pursuit of US government regulation of tobacco.
McDaniel PA; Malone RE
Tob Control; 2005 Jun; 14(3):193-200. PubMed ID: 15923470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
